RSCM
KDNY
Rock Springs Capital Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-396,280
| Closed | -$15.2M | – | 129 |
|
|
2023
Q2 | $15.2M | Sell |
396,280
-111,232
| -22% | -$4.27M | 0.36% | 65 |
|
|
2023
Q1 | $11.7M | Hold |
507,512
| – | – | 0.28% | 73 |
|
|
2022
Q4 | $13.3M | Hold |
507,512
| – | – | 0.32% | 68 |
|
|
2022
Q3 | $9.98M | Hold |
507,512
| – | – | 0.26% | 78 |
|
|
2022
Q2 | $8.88M | Sell |
507,512
-192,837
| -28% | -$3.37M | 0.26% | 82 |
|
|
2022
Q1 | $11.5M | Sell |
700,349
-20,000
| -3% | -$327K | 0.29% | 78 |
|
|
2021
Q4 | $11.7M | Buy |
720,349
+32,200
| +5% | +$525K | 0.27% | 85 |
|
|
2021
Q3 | $8.78M | Buy |
688,149
+5,700
| +0.8% | +$72.7K | 0.18% | 112 |
|
|
2021
Q2 | $9.64M | Buy |
682,449
+9,400
| +1% | +$133K | 0.19% | 117 |
|
|
2021
Q1 | $10.5M | Buy |
673,049
+4,200
| +0.6% | +$65.3K | 0.23% | 111 |
|
|
2020
Q4 | $10.6M | Buy |
+668,849
| New | +$10.6M | 0.22% | 111 |
|
|
2018
Q1 | – | Sell |
-415,000
| Closed | -$3.11M | – | 160 |
|
|
2017
Q4 | $3.11M | Hold |
415,000
| – | – | 0.14% | 123 |
|
|
2017
Q3 | $4.42M | Hold |
415,000
| – | – | 0.2% | 107 |
|
|
2017
Q2 | $4.73M | Hold |
415,000
| – | – | 0.24% | 100 |
|
|
2017
Q1 | $4.46M | Hold |
415,000
| – | – | 0.26% | 93 |
|
|
2016
Q4 | $4.73M | Hold |
415,000
| – | – | 0.32% | 81 |
|
|
2016
Q3 | $5.16M | Hold |
415,000
| – | – | 0.32% | 86 |
|
|
2016
Q2 | $4.69M | Hold |
415,000
| – | – | 0.35% | 85 |
|
|
2016
Q1 | $5.32M | Hold |
415,000
| – | – | 0.45% | 74 |
|
|
2015
Q4 | $11.7M | Hold |
415,000
| – | – | 0.88% | 38 |
|
|
2015
Q3 | $8.04M | Buy |
415,000
+65,000
| +19% | +$1.26M | 0.65% | 53 |
|
|
2015
Q2 | $10.6M | Buy |
+350,000
| New | +$10.6M | 0.77% | 41 |
|